<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVJT" lang="spa" raw_text_char_length="2744" raw_text_md5="c232883a9a3036560c59e730a00c4e17" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="77" id="segment-0" start_char="1">
<ORIGINAL_TEXT>La Hidroxicloroquina con Azitromicina no reduce la mortalidad por coronavirus</ORIGINAL_TEXT>
<TOKEN end_char="2" id="token-0-0" morph="none" pos="word" start_char="1">La</TOKEN>
<TOKEN end_char="20" id="token-0-1" morph="none" pos="word" start_char="4">Hidroxicloroquina</TOKEN>
<TOKEN end_char="24" id="token-0-2" morph="none" pos="word" start_char="22">con</TOKEN>
<TOKEN end_char="37" id="token-0-3" morph="none" pos="word" start_char="26">Azitromicina</TOKEN>
<TOKEN end_char="40" id="token-0-4" morph="none" pos="word" start_char="39">no</TOKEN>
<TOKEN end_char="47" id="token-0-5" morph="none" pos="word" start_char="42">reduce</TOKEN>
<TOKEN end_char="50" id="token-0-6" morph="none" pos="word" start_char="49">la</TOKEN>
<TOKEN end_char="61" id="token-0-7" morph="none" pos="word" start_char="52">mortalidad</TOKEN>
<TOKEN end_char="65" id="token-0-8" morph="none" pos="word" start_char="63">por</TOKEN>
<TOKEN end_char="77" id="token-0-9" morph="none" pos="word" start_char="67">coronavirus</TOKEN>
<TRANSLATED_TEXT>Hydroxychloroquine with azithromycin does not reduce coronavirus mortality</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="104" id="segment-1" start_char="83">
<ORIGINAL_TEXT>hidroxicloroquina | EP</ORIGINAL_TEXT>
<TOKEN end_char="99" id="token-1-0" morph="none" pos="word" start_char="83">hidroxicloroquina</TOKEN>
<TOKEN end_char="101" id="token-1-1" morph="none" pos="unknown" start_char="101">|</TOKEN>
<TOKEN end_char="104" id="token-1-2" morph="none" pos="word" start_char="103">EP</TOKEN>
<TRANSLATED_TEXT>hydroxychloroquine | EP</TRANSLATED_TEXT><DETECTED_LANGUAGE>ca</DETECTED_LANGUAGE></SEG>
<SEG end_char="357" id="segment-2" start_char="107">
<ORIGINAL_TEXT>La combinación de hidroxicloroquina (HCQ) y azitromicina (AZM) no ha resultado efectivo, ya que se ha vinculado a importantes riesgos cardiovasculares, incluida la mortalidad, en el mayor estudio de seguridad jamás realizado sobre la HCQ y la HCQ+AZM.</ORIGINAL_TEXT>
<TOKEN end_char="108" id="token-2-0" morph="none" pos="word" start_char="107">La</TOKEN>
<TOKEN end_char="120" id="token-2-1" morph="none" pos="word" start_char="110">combinación</TOKEN>
<TOKEN end_char="123" id="token-2-2" morph="none" pos="word" start_char="122">de</TOKEN>
<TOKEN end_char="141" id="token-2-3" morph="none" pos="word" start_char="125">hidroxicloroquina</TOKEN>
<TOKEN end_char="143" id="token-2-4" morph="none" pos="punct" start_char="143">(</TOKEN>
<TOKEN end_char="146" id="token-2-5" morph="none" pos="word" start_char="144">HCQ</TOKEN>
<TOKEN end_char="147" id="token-2-6" morph="none" pos="punct" start_char="147">)</TOKEN>
<TOKEN end_char="149" id="token-2-7" morph="none" pos="word" start_char="149">y</TOKEN>
<TOKEN end_char="162" id="token-2-8" morph="none" pos="word" start_char="151">azitromicina</TOKEN>
<TOKEN end_char="164" id="token-2-9" morph="none" pos="punct" start_char="164">(</TOKEN>
<TOKEN end_char="167" id="token-2-10" morph="none" pos="word" start_char="165">AZM</TOKEN>
<TOKEN end_char="168" id="token-2-11" morph="none" pos="punct" start_char="168">)</TOKEN>
<TOKEN end_char="171" id="token-2-12" morph="none" pos="word" start_char="170">no</TOKEN>
<TOKEN end_char="174" id="token-2-13" morph="none" pos="word" start_char="173">ha</TOKEN>
<TOKEN end_char="184" id="token-2-14" morph="none" pos="word" start_char="176">resultado</TOKEN>
<TOKEN end_char="193" id="token-2-15" morph="none" pos="word" start_char="186">efectivo</TOKEN>
<TOKEN end_char="194" id="token-2-16" morph="none" pos="punct" start_char="194">,</TOKEN>
<TOKEN end_char="197" id="token-2-17" morph="none" pos="word" start_char="196">ya</TOKEN>
<TOKEN end_char="201" id="token-2-18" morph="none" pos="word" start_char="199">que</TOKEN>
<TOKEN end_char="204" id="token-2-19" morph="none" pos="word" start_char="203">se</TOKEN>
<TOKEN end_char="207" id="token-2-20" morph="none" pos="word" start_char="206">ha</TOKEN>
<TOKEN end_char="217" id="token-2-21" morph="none" pos="word" start_char="209">vinculado</TOKEN>
<TOKEN end_char="219" id="token-2-22" morph="none" pos="word" start_char="219">a</TOKEN>
<TOKEN end_char="231" id="token-2-23" morph="none" pos="word" start_char="221">importantes</TOKEN>
<TOKEN end_char="239" id="token-2-24" morph="none" pos="word" start_char="233">riesgos</TOKEN>
<TOKEN end_char="256" id="token-2-25" morph="none" pos="word" start_char="241">cardiovasculares</TOKEN>
<TOKEN end_char="257" id="token-2-26" morph="none" pos="punct" start_char="257">,</TOKEN>
<TOKEN end_char="266" id="token-2-27" morph="none" pos="word" start_char="259">incluida</TOKEN>
<TOKEN end_char="269" id="token-2-28" morph="none" pos="word" start_char="268">la</TOKEN>
<TOKEN end_char="280" id="token-2-29" morph="none" pos="word" start_char="271">mortalidad</TOKEN>
<TOKEN end_char="281" id="token-2-30" morph="none" pos="punct" start_char="281">,</TOKEN>
<TOKEN end_char="284" id="token-2-31" morph="none" pos="word" start_char="283">en</TOKEN>
<TOKEN end_char="287" id="token-2-32" morph="none" pos="word" start_char="286">el</TOKEN>
<TOKEN end_char="293" id="token-2-33" morph="none" pos="word" start_char="289">mayor</TOKEN>
<TOKEN end_char="301" id="token-2-34" morph="none" pos="word" start_char="295">estudio</TOKEN>
<TOKEN end_char="304" id="token-2-35" morph="none" pos="word" start_char="303">de</TOKEN>
<TOKEN end_char="314" id="token-2-36" morph="none" pos="word" start_char="306">seguridad</TOKEN>
<TOKEN end_char="320" id="token-2-37" morph="none" pos="word" start_char="316">jamás</TOKEN>
<TOKEN end_char="330" id="token-2-38" morph="none" pos="word" start_char="322">realizado</TOKEN>
<TOKEN end_char="336" id="token-2-39" morph="none" pos="word" start_char="332">sobre</TOKEN>
<TOKEN end_char="339" id="token-2-40" morph="none" pos="word" start_char="338">la</TOKEN>
<TOKEN end_char="343" id="token-2-41" morph="none" pos="word" start_char="341">HCQ</TOKEN>
<TOKEN end_char="345" id="token-2-42" morph="none" pos="word" start_char="345">y</TOKEN>
<TOKEN end_char="348" id="token-2-43" morph="none" pos="word" start_char="347">la</TOKEN>
<TOKEN end_char="356" id="token-2-44" morph="none" pos="unknown" start_char="350">HCQ+AZM</TOKEN>
<TOKEN end_char="357" id="token-2-45" morph="none" pos="punct" start_char="357">.</TOKEN>
<TRANSLATED_TEXT>The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has not been effective, as it has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever conducted on HCQ and HCQ + AZM.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="714" id="segment-3" start_char="360">
<ORIGINAL_TEXT>En los pacientes con artritis reumatoide, se comprobó que el tratamiento con HCQ a corto plazo (30 días) no conlleva un riesgo excesivo de complicaciones asociadas a su uso, pero el tratamiento con HCQ a largo plazo tuvo un aumento relativo del 65 por ciento en la mortalidad relacionada con el sistema cardiovascular, en comparación con la sulfasalazina.</ORIGINAL_TEXT>
<TOKEN end_char="361" id="token-3-0" morph="none" pos="word" start_char="360">En</TOKEN>
<TOKEN end_char="365" id="token-3-1" morph="none" pos="word" start_char="363">los</TOKEN>
<TOKEN end_char="375" id="token-3-2" morph="none" pos="word" start_char="367">pacientes</TOKEN>
<TOKEN end_char="379" id="token-3-3" morph="none" pos="word" start_char="377">con</TOKEN>
<TOKEN end_char="388" id="token-3-4" morph="none" pos="word" start_char="381">artritis</TOKEN>
<TOKEN end_char="399" id="token-3-5" morph="none" pos="word" start_char="390">reumatoide</TOKEN>
<TOKEN end_char="400" id="token-3-6" morph="none" pos="punct" start_char="400">,</TOKEN>
<TOKEN end_char="403" id="token-3-7" morph="none" pos="word" start_char="402">se</TOKEN>
<TOKEN end_char="412" id="token-3-8" morph="none" pos="word" start_char="405">comprobó</TOKEN>
<TOKEN end_char="416" id="token-3-9" morph="none" pos="word" start_char="414">que</TOKEN>
<TOKEN end_char="419" id="token-3-10" morph="none" pos="word" start_char="418">el</TOKEN>
<TOKEN end_char="431" id="token-3-11" morph="none" pos="word" start_char="421">tratamiento</TOKEN>
<TOKEN end_char="435" id="token-3-12" morph="none" pos="word" start_char="433">con</TOKEN>
<TOKEN end_char="439" id="token-3-13" morph="none" pos="word" start_char="437">HCQ</TOKEN>
<TOKEN end_char="441" id="token-3-14" morph="none" pos="word" start_char="441">a</TOKEN>
<TOKEN end_char="447" id="token-3-15" morph="none" pos="word" start_char="443">corto</TOKEN>
<TOKEN end_char="453" id="token-3-16" morph="none" pos="word" start_char="449">plazo</TOKEN>
<TOKEN end_char="455" id="token-3-17" morph="none" pos="punct" start_char="455">(</TOKEN>
<TOKEN end_char="457" id="token-3-18" morph="none" pos="word" start_char="456">30</TOKEN>
<TOKEN end_char="462" id="token-3-19" morph="none" pos="word" start_char="459">días</TOKEN>
<TOKEN end_char="463" id="token-3-20" morph="none" pos="punct" start_char="463">)</TOKEN>
<TOKEN end_char="466" id="token-3-21" morph="none" pos="word" start_char="465">no</TOKEN>
<TOKEN end_char="475" id="token-3-22" morph="none" pos="word" start_char="468">conlleva</TOKEN>
<TOKEN end_char="478" id="token-3-23" morph="none" pos="word" start_char="477">un</TOKEN>
<TOKEN end_char="485" id="token-3-24" morph="none" pos="word" start_char="480">riesgo</TOKEN>
<TOKEN end_char="494" id="token-3-25" morph="none" pos="word" start_char="487">excesivo</TOKEN>
<TOKEN end_char="497" id="token-3-26" morph="none" pos="word" start_char="496">de</TOKEN>
<TOKEN end_char="512" id="token-3-27" morph="none" pos="word" start_char="499">complicaciones</TOKEN>
<TOKEN end_char="522" id="token-3-28" morph="none" pos="word" start_char="514">asociadas</TOKEN>
<TOKEN end_char="524" id="token-3-29" morph="none" pos="word" start_char="524">a</TOKEN>
<TOKEN end_char="527" id="token-3-30" morph="none" pos="word" start_char="526">su</TOKEN>
<TOKEN end_char="531" id="token-3-31" morph="none" pos="word" start_char="529">uso</TOKEN>
<TOKEN end_char="532" id="token-3-32" morph="none" pos="punct" start_char="532">,</TOKEN>
<TOKEN end_char="537" id="token-3-33" morph="none" pos="word" start_char="534">pero</TOKEN>
<TOKEN end_char="540" id="token-3-34" morph="none" pos="word" start_char="539">el</TOKEN>
<TOKEN end_char="552" id="token-3-35" morph="none" pos="word" start_char="542">tratamiento</TOKEN>
<TOKEN end_char="556" id="token-3-36" morph="none" pos="word" start_char="554">con</TOKEN>
<TOKEN end_char="560" id="token-3-37" morph="none" pos="word" start_char="558">HCQ</TOKEN>
<TOKEN end_char="562" id="token-3-38" morph="none" pos="word" start_char="562">a</TOKEN>
<TOKEN end_char="568" id="token-3-39" morph="none" pos="word" start_char="564">largo</TOKEN>
<TOKEN end_char="574" id="token-3-40" morph="none" pos="word" start_char="570">plazo</TOKEN>
<TOKEN end_char="579" id="token-3-41" morph="none" pos="word" start_char="576">tuvo</TOKEN>
<TOKEN end_char="582" id="token-3-42" morph="none" pos="word" start_char="581">un</TOKEN>
<TOKEN end_char="590" id="token-3-43" morph="none" pos="word" start_char="584">aumento</TOKEN>
<TOKEN end_char="599" id="token-3-44" morph="none" pos="word" start_char="592">relativo</TOKEN>
<TOKEN end_char="603" id="token-3-45" morph="none" pos="word" start_char="601">del</TOKEN>
<TOKEN end_char="606" id="token-3-46" morph="none" pos="word" start_char="605">65</TOKEN>
<TOKEN end_char="610" id="token-3-47" morph="none" pos="word" start_char="608">por</TOKEN>
<TOKEN end_char="617" id="token-3-48" morph="none" pos="word" start_char="612">ciento</TOKEN>
<TOKEN end_char="620" id="token-3-49" morph="none" pos="word" start_char="619">en</TOKEN>
<TOKEN end_char="623" id="token-3-50" morph="none" pos="word" start_char="622">la</TOKEN>
<TOKEN end_char="634" id="token-3-51" morph="none" pos="word" start_char="625">mortalidad</TOKEN>
<TOKEN end_char="646" id="token-3-52" morph="none" pos="word" start_char="636">relacionada</TOKEN>
<TOKEN end_char="650" id="token-3-53" morph="none" pos="word" start_char="648">con</TOKEN>
<TOKEN end_char="653" id="token-3-54" morph="none" pos="word" start_char="652">el</TOKEN>
<TOKEN end_char="661" id="token-3-55" morph="none" pos="word" start_char="655">sistema</TOKEN>
<TOKEN end_char="676" id="token-3-56" morph="none" pos="word" start_char="663">cardiovascular</TOKEN>
<TOKEN end_char="677" id="token-3-57" morph="none" pos="punct" start_char="677">,</TOKEN>
<TOKEN end_char="680" id="token-3-58" morph="none" pos="word" start_char="679">en</TOKEN>
<TOKEN end_char="692" id="token-3-59" morph="none" pos="word" start_char="682">comparación</TOKEN>
<TOKEN end_char="696" id="token-3-60" morph="none" pos="word" start_char="694">con</TOKEN>
<TOKEN end_char="699" id="token-3-61" morph="none" pos="word" start_char="698">la</TOKEN>
<TOKEN end_char="713" id="token-3-62" morph="none" pos="word" start_char="701">sulfasalazina</TOKEN>
<TOKEN end_char="714" id="token-3-63" morph="none" pos="punct" start_char="714">.</TOKEN>
<TRANSLATED_TEXT>In patients with rheumatoid arthritis, short-term (30-day) HCQ treatment was found not to carry an excessive risk of complications associated with its use, but long-term HCQ treatment had a relative 65% increase in cardiovascular-related mortality compared to sulfasalazine.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="749" id="segment-4" start_char="717">
<ORIGINAL_TEXT>Duplicaba el riesgo de mortalidad</ORIGINAL_TEXT>
<TOKEN end_char="725" id="token-4-0" morph="none" pos="word" start_char="717">Duplicaba</TOKEN>
<TOKEN end_char="728" id="token-4-1" morph="none" pos="word" start_char="727">el</TOKEN>
<TOKEN end_char="735" id="token-4-2" morph="none" pos="word" start_char="730">riesgo</TOKEN>
<TOKEN end_char="738" id="token-4-3" morph="none" pos="word" start_char="737">de</TOKEN>
<TOKEN end_char="749" id="token-4-4" morph="none" pos="word" start_char="740">mortalidad</TOKEN>
<TRANSLATED_TEXT>Duplicating the Mortality Risk</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="982" id="segment-5" start_char="753">
<ORIGINAL_TEXT>La hidroxicloroquina y azitromicina tenía un riesgo de mortalidad cardiovascular más del doble (2,19) que el tratamiento comparativo, incluso a corto plazo, según los resultados de más de 320.000 usuarios de esa terapia combinada.</ORIGINAL_TEXT>
<TOKEN end_char="754" id="token-5-0" morph="none" pos="word" start_char="753">La</TOKEN>
<TOKEN end_char="772" id="token-5-1" morph="none" pos="word" start_char="756">hidroxicloroquina</TOKEN>
<TOKEN end_char="774" id="token-5-2" morph="none" pos="word" start_char="774">y</TOKEN>
<TOKEN end_char="787" id="token-5-3" morph="none" pos="word" start_char="776">azitromicina</TOKEN>
<TOKEN end_char="793" id="token-5-4" morph="none" pos="word" start_char="789">tenía</TOKEN>
<TOKEN end_char="796" id="token-5-5" morph="none" pos="word" start_char="795">un</TOKEN>
<TOKEN end_char="803" id="token-5-6" morph="none" pos="word" start_char="798">riesgo</TOKEN>
<TOKEN end_char="806" id="token-5-7" morph="none" pos="word" start_char="805">de</TOKEN>
<TOKEN end_char="817" id="token-5-8" morph="none" pos="word" start_char="808">mortalidad</TOKEN>
<TOKEN end_char="832" id="token-5-9" morph="none" pos="word" start_char="819">cardiovascular</TOKEN>
<TOKEN end_char="836" id="token-5-10" morph="none" pos="word" start_char="834">más</TOKEN>
<TOKEN end_char="840" id="token-5-11" morph="none" pos="word" start_char="838">del</TOKEN>
<TOKEN end_char="846" id="token-5-12" morph="none" pos="word" start_char="842">doble</TOKEN>
<TOKEN end_char="848" id="token-5-13" morph="none" pos="punct" start_char="848">(</TOKEN>
<TOKEN end_char="852" id="token-5-14" morph="none" pos="unknown" start_char="849">2,19</TOKEN>
<TOKEN end_char="853" id="token-5-15" morph="none" pos="punct" start_char="853">)</TOKEN>
<TOKEN end_char="857" id="token-5-16" morph="none" pos="word" start_char="855">que</TOKEN>
<TOKEN end_char="860" id="token-5-17" morph="none" pos="word" start_char="859">el</TOKEN>
<TOKEN end_char="872" id="token-5-18" morph="none" pos="word" start_char="862">tratamiento</TOKEN>
<TOKEN end_char="884" id="token-5-19" morph="none" pos="word" start_char="874">comparativo</TOKEN>
<TOKEN end_char="885" id="token-5-20" morph="none" pos="punct" start_char="885">,</TOKEN>
<TOKEN end_char="893" id="token-5-21" morph="none" pos="word" start_char="887">incluso</TOKEN>
<TOKEN end_char="895" id="token-5-22" morph="none" pos="word" start_char="895">a</TOKEN>
<TOKEN end_char="901" id="token-5-23" morph="none" pos="word" start_char="897">corto</TOKEN>
<TOKEN end_char="907" id="token-5-24" morph="none" pos="word" start_char="903">plazo</TOKEN>
<TOKEN end_char="908" id="token-5-25" morph="none" pos="punct" start_char="908">,</TOKEN>
<TOKEN end_char="914" id="token-5-26" morph="none" pos="word" start_char="910">según</TOKEN>
<TOKEN end_char="918" id="token-5-27" morph="none" pos="word" start_char="916">los</TOKEN>
<TOKEN end_char="929" id="token-5-28" morph="none" pos="word" start_char="920">resultados</TOKEN>
<TOKEN end_char="932" id="token-5-29" morph="none" pos="word" start_char="931">de</TOKEN>
<TOKEN end_char="936" id="token-5-30" morph="none" pos="word" start_char="934">más</TOKEN>
<TOKEN end_char="939" id="token-5-31" morph="none" pos="word" start_char="938">de</TOKEN>
<TOKEN end_char="947" id="token-5-32" morph="none" pos="word" start_char="941">320.000</TOKEN>
<TOKEN end_char="956" id="token-5-33" morph="none" pos="word" start_char="949">usuarios</TOKEN>
<TOKEN end_char="959" id="token-5-34" morph="none" pos="word" start_char="958">de</TOKEN>
<TOKEN end_char="963" id="token-5-35" morph="none" pos="word" start_char="961">esa</TOKEN>
<TOKEN end_char="971" id="token-5-36" morph="none" pos="word" start_char="965">terapia</TOKEN>
<TOKEN end_char="981" id="token-5-37" morph="none" pos="word" start_char="973">combinada</TOKEN>
<TOKEN end_char="982" id="token-5-38" morph="none" pos="punct" start_char="982">.</TOKEN>
<TRANSLATED_TEXT>Hydroxychloroquine and azithromycin had a risk of cardiovascular mortality more than double (2.19) than the comparative treatment, even in the short term, according to the results of more than 320,000 users of this combined therapy.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1125" id="segment-6" start_char="984">
<ORIGINAL_TEXT>Este tratamiento también se incrementó del 15 al 20 por ciento en la tasa de angina de pecho/dolor en el pecho y en la insuficiencia cardíaca.</ORIGINAL_TEXT>
<TOKEN end_char="987" id="token-6-0" morph="none" pos="word" start_char="984">Este</TOKEN>
<TOKEN end_char="999" id="token-6-1" morph="none" pos="word" start_char="989">tratamiento</TOKEN>
<TOKEN end_char="1007" id="token-6-2" morph="none" pos="word" start_char="1001">también</TOKEN>
<TOKEN end_char="1010" id="token-6-3" morph="none" pos="word" start_char="1009">se</TOKEN>
<TOKEN end_char="1021" id="token-6-4" morph="none" pos="word" start_char="1012">incrementó</TOKEN>
<TOKEN end_char="1025" id="token-6-5" morph="none" pos="word" start_char="1023">del</TOKEN>
<TOKEN end_char="1028" id="token-6-6" morph="none" pos="word" start_char="1027">15</TOKEN>
<TOKEN end_char="1031" id="token-6-7" morph="none" pos="word" start_char="1030">al</TOKEN>
<TOKEN end_char="1034" id="token-6-8" morph="none" pos="word" start_char="1033">20</TOKEN>
<TOKEN end_char="1038" id="token-6-9" morph="none" pos="word" start_char="1036">por</TOKEN>
<TOKEN end_char="1045" id="token-6-10" morph="none" pos="word" start_char="1040">ciento</TOKEN>
<TOKEN end_char="1048" id="token-6-11" morph="none" pos="word" start_char="1047">en</TOKEN>
<TOKEN end_char="1051" id="token-6-12" morph="none" pos="word" start_char="1050">la</TOKEN>
<TOKEN end_char="1056" id="token-6-13" morph="none" pos="word" start_char="1053">tasa</TOKEN>
<TOKEN end_char="1059" id="token-6-14" morph="none" pos="word" start_char="1058">de</TOKEN>
<TOKEN end_char="1066" id="token-6-15" morph="none" pos="word" start_char="1061">angina</TOKEN>
<TOKEN end_char="1069" id="token-6-16" morph="none" pos="word" start_char="1068">de</TOKEN>
<TOKEN end_char="1081" id="token-6-17" morph="none" pos="unknown" start_char="1071">pecho/dolor</TOKEN>
<TOKEN end_char="1084" id="token-6-18" morph="none" pos="word" start_char="1083">en</TOKEN>
<TOKEN end_char="1087" id="token-6-19" morph="none" pos="word" start_char="1086">el</TOKEN>
<TOKEN end_char="1093" id="token-6-20" morph="none" pos="word" start_char="1089">pecho</TOKEN>
<TOKEN end_char="1095" id="token-6-21" morph="none" pos="word" start_char="1095">y</TOKEN>
<TOKEN end_char="1098" id="token-6-22" morph="none" pos="word" start_char="1097">en</TOKEN>
<TOKEN end_char="1101" id="token-6-23" morph="none" pos="word" start_char="1100">la</TOKEN>
<TOKEN end_char="1115" id="token-6-24" morph="none" pos="word" start_char="1103">insuficiencia</TOKEN>
<TOKEN end_char="1124" id="token-6-25" morph="none" pos="word" start_char="1117">cardíaca</TOKEN>
<TOKEN end_char="1125" id="token-6-26" morph="none" pos="punct" start_char="1125">.</TOKEN>
<TRANSLATED_TEXT>This treatment also increased from 15 to 20 percent in the rate of angina pectoris / chest pain and in heart failure.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1341" id="segment-7" start_char="1128">
<ORIGINAL_TEXT>La hidroxicloroquina, un medicamento utilizado comúnmente en el tratamiento del paludismo, el lupus y la artritis reumatoide (AR), recibió atención temprana durante la pandemia como posible tratamiento de COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="1129" id="token-7-0" morph="none" pos="word" start_char="1128">La</TOKEN>
<TOKEN end_char="1147" id="token-7-1" morph="none" pos="word" start_char="1131">hidroxicloroquina</TOKEN>
<TOKEN end_char="1148" id="token-7-2" morph="none" pos="punct" start_char="1148">,</TOKEN>
<TOKEN end_char="1151" id="token-7-3" morph="none" pos="word" start_char="1150">un</TOKEN>
<TOKEN end_char="1163" id="token-7-4" morph="none" pos="word" start_char="1153">medicamento</TOKEN>
<TOKEN end_char="1173" id="token-7-5" morph="none" pos="word" start_char="1165">utilizado</TOKEN>
<TOKEN end_char="1184" id="token-7-6" morph="none" pos="word" start_char="1175">comúnmente</TOKEN>
<TOKEN end_char="1187" id="token-7-7" morph="none" pos="word" start_char="1186">en</TOKEN>
<TOKEN end_char="1190" id="token-7-8" morph="none" pos="word" start_char="1189">el</TOKEN>
<TOKEN end_char="1202" id="token-7-9" morph="none" pos="word" start_char="1192">tratamiento</TOKEN>
<TOKEN end_char="1206" id="token-7-10" morph="none" pos="word" start_char="1204">del</TOKEN>
<TOKEN end_char="1216" id="token-7-11" morph="none" pos="word" start_char="1208">paludismo</TOKEN>
<TOKEN end_char="1217" id="token-7-12" morph="none" pos="punct" start_char="1217">,</TOKEN>
<TOKEN end_char="1220" id="token-7-13" morph="none" pos="word" start_char="1219">el</TOKEN>
<TOKEN end_char="1226" id="token-7-14" morph="none" pos="word" start_char="1222">lupus</TOKEN>
<TOKEN end_char="1228" id="token-7-15" morph="none" pos="word" start_char="1228">y</TOKEN>
<TOKEN end_char="1231" id="token-7-16" morph="none" pos="word" start_char="1230">la</TOKEN>
<TOKEN end_char="1240" id="token-7-17" morph="none" pos="word" start_char="1233">artritis</TOKEN>
<TOKEN end_char="1251" id="token-7-18" morph="none" pos="word" start_char="1242">reumatoide</TOKEN>
<TOKEN end_char="1253" id="token-7-19" morph="none" pos="punct" start_char="1253">(</TOKEN>
<TOKEN end_char="1255" id="token-7-20" morph="none" pos="word" start_char="1254">AR</TOKEN>
<TOKEN end_char="1257" id="token-7-21" morph="none" pos="punct" start_char="1256">),</TOKEN>
<TOKEN end_char="1265" id="token-7-22" morph="none" pos="word" start_char="1259">recibió</TOKEN>
<TOKEN end_char="1274" id="token-7-23" morph="none" pos="word" start_char="1267">atención</TOKEN>
<TOKEN end_char="1283" id="token-7-24" morph="none" pos="word" start_char="1276">temprana</TOKEN>
<TOKEN end_char="1291" id="token-7-25" morph="none" pos="word" start_char="1285">durante</TOKEN>
<TOKEN end_char="1294" id="token-7-26" morph="none" pos="word" start_char="1293">la</TOKEN>
<TOKEN end_char="1303" id="token-7-27" morph="none" pos="word" start_char="1296">pandemia</TOKEN>
<TOKEN end_char="1308" id="token-7-28" morph="none" pos="word" start_char="1305">como</TOKEN>
<TOKEN end_char="1316" id="token-7-29" morph="none" pos="word" start_char="1310">posible</TOKEN>
<TOKEN end_char="1328" id="token-7-30" morph="none" pos="word" start_char="1318">tratamiento</TOKEN>
<TOKEN end_char="1331" id="token-7-31" morph="none" pos="word" start_char="1330">de</TOKEN>
<TOKEN end_char="1340" id="token-7-32" morph="none" pos="unknown" start_char="1333">COVID-19</TOKEN>
<TOKEN end_char="1341" id="token-7-33" morph="none" pos="punct" start_char="1341">.</TOKEN>
<TRANSLATED_TEXT>Hydrochloroquine, a drug commonly used in the treatment of malaria, lupus and rheumatoid arthritis (RA), received early attention during the pandemic as a possible treatment of COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1532" id="segment-8" start_char="1344">
<ORIGINAL_TEXT>El perfil de seguridad a corto plazo no identificó un exceso de riesgo en ninguno de los 16 eventos adversos graves en comparación con un fármaco similar para la AR, la sulfasalazina (SSZ).</ORIGINAL_TEXT>
<TOKEN end_char="1345" id="token-8-0" morph="none" pos="word" start_char="1344">El</TOKEN>
<TOKEN end_char="1352" id="token-8-1" morph="none" pos="word" start_char="1347">perfil</TOKEN>
<TOKEN end_char="1355" id="token-8-2" morph="none" pos="word" start_char="1354">de</TOKEN>
<TOKEN end_char="1365" id="token-8-3" morph="none" pos="word" start_char="1357">seguridad</TOKEN>
<TOKEN end_char="1367" id="token-8-4" morph="none" pos="word" start_char="1367">a</TOKEN>
<TOKEN end_char="1373" id="token-8-5" morph="none" pos="word" start_char="1369">corto</TOKEN>
<TOKEN end_char="1379" id="token-8-6" morph="none" pos="word" start_char="1375">plazo</TOKEN>
<TOKEN end_char="1382" id="token-8-7" morph="none" pos="word" start_char="1381">no</TOKEN>
<TOKEN end_char="1393" id="token-8-8" morph="none" pos="word" start_char="1384">identificó</TOKEN>
<TOKEN end_char="1396" id="token-8-9" morph="none" pos="word" start_char="1395">un</TOKEN>
<TOKEN end_char="1403" id="token-8-10" morph="none" pos="word" start_char="1398">exceso</TOKEN>
<TOKEN end_char="1406" id="token-8-11" morph="none" pos="word" start_char="1405">de</TOKEN>
<TOKEN end_char="1413" id="token-8-12" morph="none" pos="word" start_char="1408">riesgo</TOKEN>
<TOKEN end_char="1416" id="token-8-13" morph="none" pos="word" start_char="1415">en</TOKEN>
<TOKEN end_char="1424" id="token-8-14" morph="none" pos="word" start_char="1418">ninguno</TOKEN>
<TOKEN end_char="1427" id="token-8-15" morph="none" pos="word" start_char="1426">de</TOKEN>
<TOKEN end_char="1431" id="token-8-16" morph="none" pos="word" start_char="1429">los</TOKEN>
<TOKEN end_char="1434" id="token-8-17" morph="none" pos="word" start_char="1433">16</TOKEN>
<TOKEN end_char="1442" id="token-8-18" morph="none" pos="word" start_char="1436">eventos</TOKEN>
<TOKEN end_char="1451" id="token-8-19" morph="none" pos="word" start_char="1444">adversos</TOKEN>
<TOKEN end_char="1458" id="token-8-20" morph="none" pos="word" start_char="1453">graves</TOKEN>
<TOKEN end_char="1461" id="token-8-21" morph="none" pos="word" start_char="1460">en</TOKEN>
<TOKEN end_char="1473" id="token-8-22" morph="none" pos="word" start_char="1463">comparación</TOKEN>
<TOKEN end_char="1477" id="token-8-23" morph="none" pos="word" start_char="1475">con</TOKEN>
<TOKEN end_char="1480" id="token-8-24" morph="none" pos="word" start_char="1479">un</TOKEN>
<TOKEN end_char="1488" id="token-8-25" morph="none" pos="word" start_char="1482">fármaco</TOKEN>
<TOKEN end_char="1496" id="token-8-26" morph="none" pos="word" start_char="1490">similar</TOKEN>
<TOKEN end_char="1501" id="token-8-27" morph="none" pos="word" start_char="1498">para</TOKEN>
<TOKEN end_char="1504" id="token-8-28" morph="none" pos="word" start_char="1503">la</TOKEN>
<TOKEN end_char="1507" id="token-8-29" morph="none" pos="word" start_char="1506">AR</TOKEN>
<TOKEN end_char="1508" id="token-8-30" morph="none" pos="punct" start_char="1508">,</TOKEN>
<TOKEN end_char="1511" id="token-8-31" morph="none" pos="word" start_char="1510">la</TOKEN>
<TOKEN end_char="1525" id="token-8-32" morph="none" pos="word" start_char="1513">sulfasalazina</TOKEN>
<TOKEN end_char="1527" id="token-8-33" morph="none" pos="punct" start_char="1527">(</TOKEN>
<TOKEN end_char="1530" id="token-8-34" morph="none" pos="word" start_char="1528">SSZ</TOKEN>
<TOKEN end_char="1532" id="token-8-35" morph="none" pos="punct" start_char="1531">).</TOKEN>
<TRANSLATED_TEXT>The short-term safety profile did not identify an excess risk in any of the 16 serious adverse events compared to a similar AR drug, sulfasalazine (SSZ).</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1670" id="segment-9" start_char="1534">
<ORIGINAL_TEXT>El tratamiento de HCQ a largo plazo se asoció con un aumento del 65 por ciento de la mortalidad cardiovascular en comparación con la SSZ.</ORIGINAL_TEXT>
<TOKEN end_char="1535" id="token-9-0" morph="none" pos="word" start_char="1534">El</TOKEN>
<TOKEN end_char="1547" id="token-9-1" morph="none" pos="word" start_char="1537">tratamiento</TOKEN>
<TOKEN end_char="1550" id="token-9-2" morph="none" pos="word" start_char="1549">de</TOKEN>
<TOKEN end_char="1554" id="token-9-3" morph="none" pos="word" start_char="1552">HCQ</TOKEN>
<TOKEN end_char="1556" id="token-9-4" morph="none" pos="word" start_char="1556">a</TOKEN>
<TOKEN end_char="1562" id="token-9-5" morph="none" pos="word" start_char="1558">largo</TOKEN>
<TOKEN end_char="1568" id="token-9-6" morph="none" pos="word" start_char="1564">plazo</TOKEN>
<TOKEN end_char="1571" id="token-9-7" morph="none" pos="word" start_char="1570">se</TOKEN>
<TOKEN end_char="1578" id="token-9-8" morph="none" pos="word" start_char="1573">asoció</TOKEN>
<TOKEN end_char="1582" id="token-9-9" morph="none" pos="word" start_char="1580">con</TOKEN>
<TOKEN end_char="1585" id="token-9-10" morph="none" pos="word" start_char="1584">un</TOKEN>
<TOKEN end_char="1593" id="token-9-11" morph="none" pos="word" start_char="1587">aumento</TOKEN>
<TOKEN end_char="1597" id="token-9-12" morph="none" pos="word" start_char="1595">del</TOKEN>
<TOKEN end_char="1600" id="token-9-13" morph="none" pos="word" start_char="1599">65</TOKEN>
<TOKEN end_char="1604" id="token-9-14" morph="none" pos="word" start_char="1602">por</TOKEN>
<TOKEN end_char="1611" id="token-9-15" morph="none" pos="word" start_char="1606">ciento</TOKEN>
<TOKEN end_char="1614" id="token-9-16" morph="none" pos="word" start_char="1613">de</TOKEN>
<TOKEN end_char="1617" id="token-9-17" morph="none" pos="word" start_char="1616">la</TOKEN>
<TOKEN end_char="1628" id="token-9-18" morph="none" pos="word" start_char="1619">mortalidad</TOKEN>
<TOKEN end_char="1643" id="token-9-19" morph="none" pos="word" start_char="1630">cardiovascular</TOKEN>
<TOKEN end_char="1646" id="token-9-20" morph="none" pos="word" start_char="1645">en</TOKEN>
<TOKEN end_char="1658" id="token-9-21" morph="none" pos="word" start_char="1648">comparación</TOKEN>
<TOKEN end_char="1662" id="token-9-22" morph="none" pos="word" start_char="1660">con</TOKEN>
<TOKEN end_char="1665" id="token-9-23" morph="none" pos="word" start_char="1664">la</TOKEN>
<TOKEN end_char="1669" id="token-9-24" morph="none" pos="word" start_char="1667">SSZ</TOKEN>
<TOKEN end_char="1670" id="token-9-25" morph="none" pos="punct" start_char="1670">.</TOKEN>
<TRANSLATED_TEXT>Long-term HCQ treatment was associated with a 65% increase in cardiovascular mortality compared to SSZ.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1728" id="segment-10" start_char="1673">
<ORIGINAL_TEXT>Juntos provoca daños como la mortabilidad cardiovascular</ORIGINAL_TEXT>
<TOKEN end_char="1678" id="token-10-0" morph="none" pos="word" start_char="1673">Juntos</TOKEN>
<TOKEN end_char="1686" id="token-10-1" morph="none" pos="word" start_char="1680">provoca</TOKEN>
<TOKEN end_char="1692" id="token-10-2" morph="none" pos="word" start_char="1688">daños</TOKEN>
<TOKEN end_char="1697" id="token-10-3" morph="none" pos="word" start_char="1694">como</TOKEN>
<TOKEN end_char="1700" id="token-10-4" morph="none" pos="word" start_char="1699">la</TOKEN>
<TOKEN end_char="1713" id="token-10-5" morph="none" pos="word" start_char="1702">mortabilidad</TOKEN>
<TOKEN end_char="1728" id="token-10-6" morph="none" pos="word" start_char="1715">cardiovascular</TOKEN>
<TRANSLATED_TEXT>Together causes damage such as cardiovascular mortality</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1940" id="segment-11" start_char="1732">
<ORIGINAL_TEXT>«La hidroxicloroquina, tanto sola como en combinación con la azitromicina, obtuvo una fuerte consideración como posible tratamiento para el COVID sin un estudio a gran escala de su perfil de seguridad general.</ORIGINAL_TEXT>
<TOKEN end_char="1732" id="token-11-0" morph="none" pos="punct" start_char="1732">«</TOKEN>
<TOKEN end_char="1734" id="token-11-1" morph="none" pos="word" start_char="1733">La</TOKEN>
<TOKEN end_char="1752" id="token-11-2" morph="none" pos="word" start_char="1736">hidroxicloroquina</TOKEN>
<TOKEN end_char="1753" id="token-11-3" morph="none" pos="punct" start_char="1753">,</TOKEN>
<TOKEN end_char="1759" id="token-11-4" morph="none" pos="word" start_char="1755">tanto</TOKEN>
<TOKEN end_char="1764" id="token-11-5" morph="none" pos="word" start_char="1761">sola</TOKEN>
<TOKEN end_char="1769" id="token-11-6" morph="none" pos="word" start_char="1766">como</TOKEN>
<TOKEN end_char="1772" id="token-11-7" morph="none" pos="word" start_char="1771">en</TOKEN>
<TOKEN end_char="1784" id="token-11-8" morph="none" pos="word" start_char="1774">combinación</TOKEN>
<TOKEN end_char="1788" id="token-11-9" morph="none" pos="word" start_char="1786">con</TOKEN>
<TOKEN end_char="1791" id="token-11-10" morph="none" pos="word" start_char="1790">la</TOKEN>
<TOKEN end_char="1804" id="token-11-11" morph="none" pos="word" start_char="1793">azitromicina</TOKEN>
<TOKEN end_char="1805" id="token-11-12" morph="none" pos="punct" start_char="1805">,</TOKEN>
<TOKEN end_char="1812" id="token-11-13" morph="none" pos="word" start_char="1807">obtuvo</TOKEN>
<TOKEN end_char="1816" id="token-11-14" morph="none" pos="word" start_char="1814">una</TOKEN>
<TOKEN end_char="1823" id="token-11-15" morph="none" pos="word" start_char="1818">fuerte</TOKEN>
<TOKEN end_char="1837" id="token-11-16" morph="none" pos="word" start_char="1825">consideración</TOKEN>
<TOKEN end_char="1842" id="token-11-17" morph="none" pos="word" start_char="1839">como</TOKEN>
<TOKEN end_char="1850" id="token-11-18" morph="none" pos="word" start_char="1844">posible</TOKEN>
<TOKEN end_char="1862" id="token-11-19" morph="none" pos="word" start_char="1852">tratamiento</TOKEN>
<TOKEN end_char="1867" id="token-11-20" morph="none" pos="word" start_char="1864">para</TOKEN>
<TOKEN end_char="1870" id="token-11-21" morph="none" pos="word" start_char="1869">el</TOKEN>
<TOKEN end_char="1876" id="token-11-22" morph="none" pos="word" start_char="1872">COVID</TOKEN>
<TOKEN end_char="1880" id="token-11-23" morph="none" pos="word" start_char="1878">sin</TOKEN>
<TOKEN end_char="1883" id="token-11-24" morph="none" pos="word" start_char="1882">un</TOKEN>
<TOKEN end_char="1891" id="token-11-25" morph="none" pos="word" start_char="1885">estudio</TOKEN>
<TOKEN end_char="1893" id="token-11-26" morph="none" pos="word" start_char="1893">a</TOKEN>
<TOKEN end_char="1898" id="token-11-27" morph="none" pos="word" start_char="1895">gran</TOKEN>
<TOKEN end_char="1905" id="token-11-28" morph="none" pos="word" start_char="1900">escala</TOKEN>
<TOKEN end_char="1908" id="token-11-29" morph="none" pos="word" start_char="1907">de</TOKEN>
<TOKEN end_char="1911" id="token-11-30" morph="none" pos="word" start_char="1910">su</TOKEN>
<TOKEN end_char="1918" id="token-11-31" morph="none" pos="word" start_char="1913">perfil</TOKEN>
<TOKEN end_char="1921" id="token-11-32" morph="none" pos="word" start_char="1920">de</TOKEN>
<TOKEN end_char="1931" id="token-11-33" morph="none" pos="word" start_char="1923">seguridad</TOKEN>
<TOKEN end_char="1939" id="token-11-34" morph="none" pos="word" start_char="1933">general</TOKEN>
<TOKEN end_char="1940" id="token-11-35" morph="none" pos="punct" start_char="1940">.</TOKEN>
<TRANSLATED_TEXT>Hydroxychloroquine, both alone and in combination with azithromycin, received strong consideration as a possible treatment for COVID without a large-scale study of its overall safety profile.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2127" id="segment-12" start_char="1942">
<ORIGINAL_TEXT>Tuvimos acceso a una cantidad de datos sin precedentes sobre este medicamento, y nos alivió no encontrar efectos secundarios preocupantes en el uso a corto plazo de la hidroxicloroquina.</ORIGINAL_TEXT>
<TOKEN end_char="1948" id="token-12-0" morph="none" pos="word" start_char="1942">Tuvimos</TOKEN>
<TOKEN end_char="1955" id="token-12-1" morph="none" pos="word" start_char="1950">acceso</TOKEN>
<TOKEN end_char="1957" id="token-12-2" morph="none" pos="word" start_char="1957">a</TOKEN>
<TOKEN end_char="1961" id="token-12-3" morph="none" pos="word" start_char="1959">una</TOKEN>
<TOKEN end_char="1970" id="token-12-4" morph="none" pos="word" start_char="1963">cantidad</TOKEN>
<TOKEN end_char="1973" id="token-12-5" morph="none" pos="word" start_char="1972">de</TOKEN>
<TOKEN end_char="1979" id="token-12-6" morph="none" pos="word" start_char="1975">datos</TOKEN>
<TOKEN end_char="1983" id="token-12-7" morph="none" pos="word" start_char="1981">sin</TOKEN>
<TOKEN end_char="1995" id="token-12-8" morph="none" pos="word" start_char="1985">precedentes</TOKEN>
<TOKEN end_char="2001" id="token-12-9" morph="none" pos="word" start_char="1997">sobre</TOKEN>
<TOKEN end_char="2006" id="token-12-10" morph="none" pos="word" start_char="2003">este</TOKEN>
<TOKEN end_char="2018" id="token-12-11" morph="none" pos="word" start_char="2008">medicamento</TOKEN>
<TOKEN end_char="2019" id="token-12-12" morph="none" pos="punct" start_char="2019">,</TOKEN>
<TOKEN end_char="2021" id="token-12-13" morph="none" pos="word" start_char="2021">y</TOKEN>
<TOKEN end_char="2025" id="token-12-14" morph="none" pos="word" start_char="2023">nos</TOKEN>
<TOKEN end_char="2032" id="token-12-15" morph="none" pos="word" start_char="2027">alivió</TOKEN>
<TOKEN end_char="2035" id="token-12-16" morph="none" pos="word" start_char="2034">no</TOKEN>
<TOKEN end_char="2045" id="token-12-17" morph="none" pos="word" start_char="2037">encontrar</TOKEN>
<TOKEN end_char="2053" id="token-12-18" morph="none" pos="word" start_char="2047">efectos</TOKEN>
<TOKEN end_char="2065" id="token-12-19" morph="none" pos="word" start_char="2055">secundarios</TOKEN>
<TOKEN end_char="2078" id="token-12-20" morph="none" pos="word" start_char="2067">preocupantes</TOKEN>
<TOKEN end_char="2081" id="token-12-21" morph="none" pos="word" start_char="2080">en</TOKEN>
<TOKEN end_char="2084" id="token-12-22" morph="none" pos="word" start_char="2083">el</TOKEN>
<TOKEN end_char="2088" id="token-12-23" morph="none" pos="word" start_char="2086">uso</TOKEN>
<TOKEN end_char="2090" id="token-12-24" morph="none" pos="word" start_char="2090">a</TOKEN>
<TOKEN end_char="2096" id="token-12-25" morph="none" pos="word" start_char="2092">corto</TOKEN>
<TOKEN end_char="2102" id="token-12-26" morph="none" pos="word" start_char="2098">plazo</TOKEN>
<TOKEN end_char="2105" id="token-12-27" morph="none" pos="word" start_char="2104">de</TOKEN>
<TOKEN end_char="2108" id="token-12-28" morph="none" pos="word" start_char="2107">la</TOKEN>
<TOKEN end_char="2126" id="token-12-29" morph="none" pos="word" start_char="2110">hidroxicloroquina</TOKEN>
<TOKEN end_char="2127" id="token-12-30" morph="none" pos="punct" start_char="2127">.</TOKEN>
<TRANSLATED_TEXT>We had access to an unprecedented amount of data on this drug, and we were relieved not to find worrying side effects in the short-term use of hydroxychloroquine.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2392" id="segment-13" start_char="2129">
<ORIGINAL_TEXT>Sin embargo, cuando se prescribe en combinación con la azitromicina, puede inducir a la insuficiencia cardíaca y a la mortalidad cardiovascular, por lo que instamos a la prudencia en el uso de ambas», explica uno de los autores del estudio, Daniel Prieto-Alhambra.</ORIGINAL_TEXT>
<TOKEN end_char="2131" id="token-13-0" morph="none" pos="word" start_char="2129">Sin</TOKEN>
<TOKEN end_char="2139" id="token-13-1" morph="none" pos="word" start_char="2133">embargo</TOKEN>
<TOKEN end_char="2140" id="token-13-2" morph="none" pos="punct" start_char="2140">,</TOKEN>
<TOKEN end_char="2147" id="token-13-3" morph="none" pos="word" start_char="2142">cuando</TOKEN>
<TOKEN end_char="2150" id="token-13-4" morph="none" pos="word" start_char="2149">se</TOKEN>
<TOKEN end_char="2160" id="token-13-5" morph="none" pos="word" start_char="2152">prescribe</TOKEN>
<TOKEN end_char="2163" id="token-13-6" morph="none" pos="word" start_char="2162">en</TOKEN>
<TOKEN end_char="2175" id="token-13-7" morph="none" pos="word" start_char="2165">combinación</TOKEN>
<TOKEN end_char="2179" id="token-13-8" morph="none" pos="word" start_char="2177">con</TOKEN>
<TOKEN end_char="2182" id="token-13-9" morph="none" pos="word" start_char="2181">la</TOKEN>
<TOKEN end_char="2195" id="token-13-10" morph="none" pos="word" start_char="2184">azitromicina</TOKEN>
<TOKEN end_char="2196" id="token-13-11" morph="none" pos="punct" start_char="2196">,</TOKEN>
<TOKEN end_char="2202" id="token-13-12" morph="none" pos="word" start_char="2198">puede</TOKEN>
<TOKEN end_char="2210" id="token-13-13" morph="none" pos="word" start_char="2204">inducir</TOKEN>
<TOKEN end_char="2212" id="token-13-14" morph="none" pos="word" start_char="2212">a</TOKEN>
<TOKEN end_char="2215" id="token-13-15" morph="none" pos="word" start_char="2214">la</TOKEN>
<TOKEN end_char="2229" id="token-13-16" morph="none" pos="word" start_char="2217">insuficiencia</TOKEN>
<TOKEN end_char="2238" id="token-13-17" morph="none" pos="word" start_char="2231">cardíaca</TOKEN>
<TOKEN end_char="2240" id="token-13-18" morph="none" pos="word" start_char="2240">y</TOKEN>
<TOKEN end_char="2242" id="token-13-19" morph="none" pos="word" start_char="2242">a</TOKEN>
<TOKEN end_char="2245" id="token-13-20" morph="none" pos="word" start_char="2244">la</TOKEN>
<TOKEN end_char="2256" id="token-13-21" morph="none" pos="word" start_char="2247">mortalidad</TOKEN>
<TOKEN end_char="2271" id="token-13-22" morph="none" pos="word" start_char="2258">cardiovascular</TOKEN>
<TOKEN end_char="2272" id="token-13-23" morph="none" pos="punct" start_char="2272">,</TOKEN>
<TOKEN end_char="2276" id="token-13-24" morph="none" pos="word" start_char="2274">por</TOKEN>
<TOKEN end_char="2279" id="token-13-25" morph="none" pos="word" start_char="2278">lo</TOKEN>
<TOKEN end_char="2283" id="token-13-26" morph="none" pos="word" start_char="2281">que</TOKEN>
<TOKEN end_char="2292" id="token-13-27" morph="none" pos="word" start_char="2285">instamos</TOKEN>
<TOKEN end_char="2294" id="token-13-28" morph="none" pos="word" start_char="2294">a</TOKEN>
<TOKEN end_char="2297" id="token-13-29" morph="none" pos="word" start_char="2296">la</TOKEN>
<TOKEN end_char="2307" id="token-13-30" morph="none" pos="word" start_char="2299">prudencia</TOKEN>
<TOKEN end_char="2310" id="token-13-31" morph="none" pos="word" start_char="2309">en</TOKEN>
<TOKEN end_char="2313" id="token-13-32" morph="none" pos="word" start_char="2312">el</TOKEN>
<TOKEN end_char="2317" id="token-13-33" morph="none" pos="word" start_char="2315">uso</TOKEN>
<TOKEN end_char="2320" id="token-13-34" morph="none" pos="word" start_char="2319">de</TOKEN>
<TOKEN end_char="2326" id="token-13-35" morph="none" pos="word" start_char="2322">ambas</TOKEN>
<TOKEN end_char="2328" id="token-13-36" morph="none" pos="punct" start_char="2327">»,</TOKEN>
<TOKEN end_char="2336" id="token-13-37" morph="none" pos="word" start_char="2330">explica</TOKEN>
<TOKEN end_char="2340" id="token-13-38" morph="none" pos="word" start_char="2338">uno</TOKEN>
<TOKEN end_char="2343" id="token-13-39" morph="none" pos="word" start_char="2342">de</TOKEN>
<TOKEN end_char="2347" id="token-13-40" morph="none" pos="word" start_char="2345">los</TOKEN>
<TOKEN end_char="2355" id="token-13-41" morph="none" pos="word" start_char="2349">autores</TOKEN>
<TOKEN end_char="2359" id="token-13-42" morph="none" pos="word" start_char="2357">del</TOKEN>
<TOKEN end_char="2367" id="token-13-43" morph="none" pos="word" start_char="2361">estudio</TOKEN>
<TOKEN end_char="2368" id="token-13-44" morph="none" pos="punct" start_char="2368">,</TOKEN>
<TOKEN end_char="2375" id="token-13-45" morph="none" pos="word" start_char="2370">Daniel</TOKEN>
<TOKEN end_char="2391" id="token-13-46" morph="none" pos="unknown" start_char="2377">Prieto-Alhambra</TOKEN>
<TOKEN end_char="2392" id="token-13-47" morph="none" pos="punct" start_char="2392">.</TOKEN>
<TRANSLATED_TEXT>However, when prescribed in combination with azithromycin, it can induce heart failure and cardiovascular mortality, so we urge caution in the use of both, "explains one of the authors of the study, Daniel Prieto-Alhambra.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2585" id="segment-14" start_char="2395">
<ORIGINAL_TEXT>En este estudio se examinó a más de 950.000 usuarios de HCQ mediante registros sanitarios electrónicos no identificados y datos de reclamaciones administrativas durante un período de 20 años.</ORIGINAL_TEXT>
<TOKEN end_char="2396" id="token-14-0" morph="none" pos="word" start_char="2395">En</TOKEN>
<TOKEN end_char="2401" id="token-14-1" morph="none" pos="word" start_char="2398">este</TOKEN>
<TOKEN end_char="2409" id="token-14-2" morph="none" pos="word" start_char="2403">estudio</TOKEN>
<TOKEN end_char="2412" id="token-14-3" morph="none" pos="word" start_char="2411">se</TOKEN>
<TOKEN end_char="2420" id="token-14-4" morph="none" pos="word" start_char="2414">examinó</TOKEN>
<TOKEN end_char="2422" id="token-14-5" morph="none" pos="word" start_char="2422">a</TOKEN>
<TOKEN end_char="2426" id="token-14-6" morph="none" pos="word" start_char="2424">más</TOKEN>
<TOKEN end_char="2429" id="token-14-7" morph="none" pos="word" start_char="2428">de</TOKEN>
<TOKEN end_char="2437" id="token-14-8" morph="none" pos="word" start_char="2431">950.000</TOKEN>
<TOKEN end_char="2446" id="token-14-9" morph="none" pos="word" start_char="2439">usuarios</TOKEN>
<TOKEN end_char="2449" id="token-14-10" morph="none" pos="word" start_char="2448">de</TOKEN>
<TOKEN end_char="2453" id="token-14-11" morph="none" pos="word" start_char="2451">HCQ</TOKEN>
<TOKEN end_char="2462" id="token-14-12" morph="none" pos="word" start_char="2455">mediante</TOKEN>
<TOKEN end_char="2472" id="token-14-13" morph="none" pos="word" start_char="2464">registros</TOKEN>
<TOKEN end_char="2483" id="token-14-14" morph="none" pos="word" start_char="2474">sanitarios</TOKEN>
<TOKEN end_char="2496" id="token-14-15" morph="none" pos="word" start_char="2485">electrónicos</TOKEN>
<TOKEN end_char="2499" id="token-14-16" morph="none" pos="word" start_char="2498">no</TOKEN>
<TOKEN end_char="2513" id="token-14-17" morph="none" pos="word" start_char="2501">identificados</TOKEN>
<TOKEN end_char="2515" id="token-14-18" morph="none" pos="word" start_char="2515">y</TOKEN>
<TOKEN end_char="2521" id="token-14-19" morph="none" pos="word" start_char="2517">datos</TOKEN>
<TOKEN end_char="2524" id="token-14-20" morph="none" pos="word" start_char="2523">de</TOKEN>
<TOKEN end_char="2538" id="token-14-21" morph="none" pos="word" start_char="2526">reclamaciones</TOKEN>
<TOKEN end_char="2554" id="token-14-22" morph="none" pos="word" start_char="2540">administrativas</TOKEN>
<TOKEN end_char="2562" id="token-14-23" morph="none" pos="word" start_char="2556">durante</TOKEN>
<TOKEN end_char="2565" id="token-14-24" morph="none" pos="word" start_char="2564">un</TOKEN>
<TOKEN end_char="2573" id="token-14-25" morph="none" pos="word" start_char="2567">período</TOKEN>
<TOKEN end_char="2576" id="token-14-26" morph="none" pos="word" start_char="2575">de</TOKEN>
<TOKEN end_char="2579" id="token-14-27" morph="none" pos="word" start_char="2578">20</TOKEN>
<TOKEN end_char="2584" id="token-14-28" morph="none" pos="word" start_char="2581">años</TOKEN>
<TOKEN end_char="2585" id="token-14-29" morph="none" pos="punct" start_char="2585">.</TOKEN>
<TRANSLATED_TEXT>This study examined over 950,000 HCQ users using unidentified electronic health records and administrative claims data over a 20-year period.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2740" id="segment-15" start_char="2587">
<ORIGINAL_TEXT>Se recopilaron registros de 14 bases de datos diferentes que abarcaban seis naciones (Alemania, Japón, Países Bajos, España, Reino Unido, Estados Unidos).</ORIGINAL_TEXT>
<TOKEN end_char="2588" id="token-15-0" morph="none" pos="word" start_char="2587">Se</TOKEN>
<TOKEN end_char="2600" id="token-15-1" morph="none" pos="word" start_char="2590">recopilaron</TOKEN>
<TOKEN end_char="2610" id="token-15-2" morph="none" pos="word" start_char="2602">registros</TOKEN>
<TOKEN end_char="2613" id="token-15-3" morph="none" pos="word" start_char="2612">de</TOKEN>
<TOKEN end_char="2616" id="token-15-4" morph="none" pos="word" start_char="2615">14</TOKEN>
<TOKEN end_char="2622" id="token-15-5" morph="none" pos="word" start_char="2618">bases</TOKEN>
<TOKEN end_char="2625" id="token-15-6" morph="none" pos="word" start_char="2624">de</TOKEN>
<TOKEN end_char="2631" id="token-15-7" morph="none" pos="word" start_char="2627">datos</TOKEN>
<TOKEN end_char="2642" id="token-15-8" morph="none" pos="word" start_char="2633">diferentes</TOKEN>
<TOKEN end_char="2646" id="token-15-9" morph="none" pos="word" start_char="2644">que</TOKEN>
<TOKEN end_char="2656" id="token-15-10" morph="none" pos="word" start_char="2648">abarcaban</TOKEN>
<TOKEN end_char="2661" id="token-15-11" morph="none" pos="word" start_char="2658">seis</TOKEN>
<TOKEN end_char="2670" id="token-15-12" morph="none" pos="word" start_char="2663">naciones</TOKEN>
<TOKEN end_char="2672" id="token-15-13" morph="none" pos="punct" start_char="2672">(</TOKEN>
<TOKEN end_char="2680" id="token-15-14" morph="none" pos="word" start_char="2673">Alemania</TOKEN>
<TOKEN end_char="2681" id="token-15-15" morph="none" pos="punct" start_char="2681">,</TOKEN>
<TOKEN end_char="2687" id="token-15-16" morph="none" pos="word" start_char="2683">Japón</TOKEN>
<TOKEN end_char="2688" id="token-15-17" morph="none" pos="punct" start_char="2688">,</TOKEN>
<TOKEN end_char="2695" id="token-15-18" morph="none" pos="word" start_char="2690">Países</TOKEN>
<TOKEN end_char="2701" id="token-15-19" morph="none" pos="word" start_char="2697">Bajos</TOKEN>
<TOKEN end_char="2702" id="token-15-20" morph="none" pos="punct" start_char="2702">,</TOKEN>
<TOKEN end_char="2709" id="token-15-21" morph="none" pos="word" start_char="2704">España</TOKEN>
<TOKEN end_char="2710" id="token-15-22" morph="none" pos="punct" start_char="2710">,</TOKEN>
<TOKEN end_char="2716" id="token-15-23" morph="none" pos="word" start_char="2712">Reino</TOKEN>
<TOKEN end_char="2722" id="token-15-24" morph="none" pos="word" start_char="2718">Unido</TOKEN>
<TOKEN end_char="2723" id="token-15-25" morph="none" pos="punct" start_char="2723">,</TOKEN>
<TOKEN end_char="2731" id="token-15-26" morph="none" pos="word" start_char="2725">Estados</TOKEN>
<TOKEN end_char="2738" id="token-15-27" morph="none" pos="word" start_char="2733">Unidos</TOKEN>
<TOKEN end_char="2740" id="token-15-28" morph="none" pos="punct" start_char="2739">).</TOKEN>
<TRANSLATED_TEXT>Records were collected from 14 different databases covering six nations (Germany, Japan, Netherlands, Spain, United Kingdom, United States).</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>